{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fc84309b1-3081-4c06-a08a-beb3eb41a5ad","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia \u2014 Part 1 of a 3-Part Series\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/c84309b1-3081-4c06-a08a-beb3eb41a5ad\"></iframe>","title":"Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia \u2014 Part 1 of a 3-Part Series","description":"\n        <p>Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/MTPCLL24/Part1\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/cab655ac-a924-47d2-9bdc-89c7102549a8/cover.jpg"}